Documents

Files(16)

Name Size/Type Description Date
E-Carbo-X consent 116KB PDF E-Carbo-X consent 27 Sep 2021
EAP-mitotane consent 113KB PDF EAP-mitotane consent 21 Apr 2020
EC - Docetaxel consent 114KB PDF EC - Docetaxel consent 21 Apr 2020
EC consent 113KB PDF EC consent 21 Apr 2020
ECX consent 116KB PDF ECX consent 08 Sep 2022
Eflornithine compassionate use consent form 113KB PDF Eflornithine compassionate use consent form 22 Aug 2023
Elacestrant consent 112KB PDF Elacestrant consent 15 Jan 2025
Encorafenib & Binimetinib consent 112KB PDF Encorafenib & Binimetinib consent 21 Apr 2020
Enhertu (Trastuzumab deruxtecan) consent 113KB PDF Enhertu cionsent 12 May 2021
Entrectinib consent 111KB PDF Entrectinib consent 22 Dec 2020
EOX consent 116KB PDF EOX consent 05 Oct 2022
Epirubicin consent 112KB PDF Epirubicin consent 21 Apr 2020
Eribulin consent 112KB PDF Eribulin consent 21 Apr 2020
Erlotinib consent 111KB PDF Erlotinib consent 21 Apr 2020
Everolimus & Lenvatinib consent 113KB PDF Everolimus & Lenvatinib consent 21 Apr 2020
Everolimus consent 110KB PDF Everolimus consent 21 Apr 2020

Chemotherapy Consent Forms for Solid Tumours

All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information.  You may wish to take your own legal advice before using any of the consent forms.

Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.

These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.

The relevant Macmillan leaflet(s) should also be provided to each patient before consent. In no way should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.

These consent forms are for solid tumour chemotherapy only, and are NOT to be used for chemo-radiotherapy regimens.